Skip to main content
Circulars

Pharmacy Circular 002/23 Saxenda


Documents

Summary

Pharmacy Circular 002/23 – Saxenda, published on 6 January 2023, provides community pharmacists with updated HSE High Tech Scheme guidance on the prescribing, reimbursement, and dispensing arrangements for Saxenda® (liraglutide), including eligibility criteria, initiation and continuation requirements, and administrative procedures to support its use in weight management under specialist supervision.


This is a beta version - your feedback will help us to improve it

Pharmacy Circular 002/23 Saxenda